Ann: Investor presentation, page-5

In light of the recent smashing Resmed has had in the hands of the market, could this be a beneficiary of the rise in weight loss drugs? The second order thinking here is that as people loose weight and have "less severe" sleep apnea, the demand for severe sleep apnea devices will decline, and the market for mild sleep apnea will increase, therefore creating more demand for more comfortable, practical wearables such as these. If they can achieve full reimbursement for the rest assure, this could be a huge turn around play.